Next Article in Journal
Evaluation of the Quality of Life of Patients with Myasthenia Gravis in Greece
Previous Article in Journal
Performance of a Support Vector Machine Learning Tool for Diagnosing Diabetic Retinopathy in Clinical Practice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 13
Issue 7
10.3390/jpm13071129
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy

by
Takao Hamamoto
1,
Yuki Sato
1,
Kohei Yumii
1,
Nobuyuki Chikuie
1,
Takayuki Taruya
1,
Yuichiro Horibe
1,
Takashi Ishino
1,
Tsutomu Ueda
1,
Sachio Takeno
1,* and
Kenichi Yoshimura
2
1
Department of Otorhinolaryngology, Head and Neck Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan
2
Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima 734-8555, Japan
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2023, 13(7), 1129; https://doi.org/10.3390/jpm13071129
Submission received: 31 May 2023 / Revised: 7 July 2023 / Accepted: 9 July 2023 / Published: 12 July 2023
(This article belongs to the Section Personalized Therapy and Drug Delivery)
Browse Figures
Versions Notes

Abstract

Chemoradiotherapy (CRT) is the standard treatment for locally advanced head and neck cancer; however, CRT may cause post-treatment dysphagia. Transcutaneous electrical sensory stimulation (TESS), developed in recent years for swallowing rehabilitation, is used at many medical facilities. Although TESS has been used for dysphagia in several fields, its safety and efficacy in patients with head and neck cancer remain to be clarified. Therefore, this study evaluated the safety of TESS in ten patients with head and neck cancers undergoing CRT. Swallowing rehabilitation intervention and TESS implementation were performed for all patients during CRT. Non-blood-toxicity adverse events (AEs), such as dermatitis and mucositis, occurred during CRT; however, the severity was less than grade 3. No patient experienced pain due to TESS. As survival time analysis using the Kaplan–Meier method for interferential current device implementation rates revealed a feasibility of 100% for up to 60 Gy and a feasibility of 78% for up to 70 Gy, TESS may be feasible until 70 Gy. This study confirmed the feasibility and safety of TESS in the head and neck region during CRT. Although the precise mechanism of TESS on dysphagia remains unclear, its continued use has great potential for improving sensory disturbance.
Keywords: head and neck neoplasms; electric stimulation; chemoradiotherapy; swallowing; dysphagia head and neck neoplasms; electric stimulation; chemoradiotherapy; swallowing; dysphagia

Share and Cite

MDPI and ACS Style

Hamamoto, T.; Sato, Y.; Yumii, K.; Chikuie, N.; Taruya, T.; Horibe, Y.; Ishino, T.; Ueda, T.; Takeno, S.; Yoshimura, K. Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy. J. Pers. Med. 2023, 13, 1129. https://doi.org/10.3390/jpm13071129

AMA Style

Hamamoto T, Sato Y, Yumii K, Chikuie N, Taruya T, Horibe Y, Ishino T, Ueda T, Takeno S, Yoshimura K. Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy. Journal of Personalized Medicine. 2023; 13(7):1129. https://doi.org/10.3390/jpm13071129

Chicago/Turabian Style

Hamamoto, Takao, Yuki Sato, Kohei Yumii, Nobuyuki Chikuie, Takayuki Taruya, Yuichiro Horibe, Takashi Ishino, Tsutomu Ueda, Sachio Takeno, and Kenichi Yoshimura. 2023. "Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy" Journal of Personalized Medicine 13, no. 7: 1129. https://doi.org/10.3390/jpm13071129

APA Style

Hamamoto, T., Sato, Y., Yumii, K., Chikuie, N., Taruya, T., Horibe, Y., Ishino, T., Ueda, T., Takeno, S., & Yoshimura, K. (2023). Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy. Journal of Personalized Medicine, 13(7), 1129. https://doi.org/10.3390/jpm13071129

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop